Mendoza Luis A, Ocampo Genaro G, Abarca-Pineda Yozahandy A, Ahmad Khan Mubashir, Ahmadi Yasmin, Brown Najaee, Deowan Denyse, Nazir Zahra
Medicine and Surgery, Universidad Cristóbal Colón, Veracruz, MEX.
Medicine and Surgery, Westhill University, Mexico City, MEX.
Cureus. 2025 Apr 25;17(4):e82991. doi: 10.7759/cureus.82991. eCollection 2025 Apr.
Hair loss, or alopecia, is a complex disorder that impacts individuals worldwide, frequently resulting in significant psychological and social consequences. This review analyzes the multifactorial etiology, recent diagnostic innovations, and emerging treatment alternatives for hair loss management. Alopecia is classified into the cicatricial (scarring) and non-cicatricial (non-scarring) forms, each having a unique underlying pathogenesis, ranging from autoimmune dysregulation, androgenetic mechanisms, and environmental factors. Recent advancements in diagnostics, such as artificial intelligence (AI)-enhanced imaging and biomarker analysis, have improved precision and individualization of treatment. Novel therapies, such as low-dose oral minoxidil (LDOM), topical 5-alpha reductase inhibitors, and Janus kinase inhibitors (JAKi), offer a range of promising options for hair loss management. Non-invasive therapies, such as low-level laser therapy (LLLT) and platelet-rich plasma (PRP) injections, have demonstrated synergistic benefits with existing treatments. Surgical advancements, especially AI-assisted robotic follicular unit extraction (FUE), enhance precision and outcomes. Emerging trends in regenerative medicine, especially stem-cell-based therapies and AI integration, are influencing the future of customized hair restoration. This review serves as a comprehensive guide, highlighting the use of innovative technologies and therapies in enhancing the accuracy and customization of hair loss treatment.
脱发,即秃发症,是一种复杂的病症,影响着全球各地的人们,常常会导致严重的心理和社会后果。本综述分析了脱发管理的多因素病因、近期诊断创新以及新出现的治疗选择。秃发症分为瘢痕性(瘢痕形成性)和非瘢痕性(非瘢痕形成性)两种类型,每种类型都有独特的潜在发病机制,包括自身免疫失调、雄激素机制和环境因素。诊断方面的最新进展,如人工智能(AI)增强成像和生物标志物分析,提高了治疗的精准度和个性化程度。新型疗法,如低剂量口服米诺地尔(LDOM)、外用5-α还原酶抑制剂和 Janus 激酶抑制剂(JAKi),为脱发管理提供了一系列有前景的选择。非侵入性疗法,如低能量激光疗法(LLLT)和富血小板血浆(PRP)注射,已证明与现有治疗方法具有协同效益。手术方面的进展,特别是人工智能辅助的机器人毛囊单位提取(FUE),提高了精准度和治疗效果。再生医学的新兴趋势,特别是基于干细胞的疗法和与人工智能的整合,正在影响定制化毛发修复的未来。本综述作为一份全面指南,强调了创新技术和疗法在提高脱发治疗准确性和定制化方面的应用。